Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06623136 |
| Consolidated Lead Sponsor | Elpiscience (Suzhou) Biopharma |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 30 participants (ACTUAL) |
| Registered Start Date | 2025-04-30 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Henan Cancer Hospital | Zhengzhou, China | Open Hospital Dossier -> |
| The first affiliated hospital of Zhengzhou University | Zhengzhou, China | Open Hospital Dossier -> |
| The First Affiliated Hospital of Nanchang University | Nanchang, China | Open Hospital Dossier -> |
| Jilin Cancer Hospital | Changchun, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.